-- エネルギー安全保障・ネットゼロ省は木曜日、英国の太陽光発電設備の設置件数が3月に2万7000件を突破し、総設置容量が200万システムを超え、年間増加分が2.3ギガワットに達したと発表した。 同省によると、地政学的緊張の高まりを受け、政府が不安定な化石燃料市場への依存度を低減する取り組みを加速させる中、英国全土の家庭で太陽光発電の導入が進んでいる。 同省は、2026年3月に英国で2万7000件を超える太陽光発電設備が設置され、2012年以来最高の月間設置件数を記録し、総設置システム数が200万システムを突破したと付け加えた。 同省によると、太陽光発電容量は前年比11.7%増加し、国内の再生可能エネルギー発電容量が2.3ギガワット増加し、英国の国内電力生産能力が強化された。 政府は、エネルギーコストの削減とクリーンエネルギー戦略の推進のため、住宅、教育、地域社会の各分野で太陽光発電の導入拡大を継続していると述べた。 当局は、英国史上最大規模となる予定のスプリングウェル太陽光発電所の建設を承認したほか、数ヶ月以内に家庭用プラグイン式太陽光パネルの普及も進めると、同省は付け加えた。 政府はまた、分散型発電の拡大と長期的なエネルギーコストの削減を目指し、イングランドの新築住宅への太陽光パネル設置を義務付ける方針だと述べた。 同省が引用した国家エネルギー系統運用機関(NESO)のデータによると、今月、英国の電力網における太陽光発電量は初めて15ギガワット(GW)を超え、再生可能エネルギーの統合加速を反映している。 政府は、グレート・ブリティッシュ・エナジーを通じて屋上太陽光発電の導入を拡大しており、今年は100校の学校や大学への設置を支援すると、同省は述べた。 さらに、政府は社会住宅基金に1億ユーロ(1億1730万ドル)を追加配分し、今年度中に最大5万7000世帯への新規太陽光発電設備の設置を目指すと付け加えた。 「これは、世界的なエネルギーショックへの対応、光熱費の削減、そして英国の化石燃料からの脱却を支援する、我々のクリーンエネルギー政策の実践例です」と、エド・ミリバンド・エネルギー大臣は述べた。
Related Articles
ManpowerGroup Sells Jefferson Wells US Business to Sikich
ManpowerGroup (MAN) said Thursday it is selling its Jefferson Wells US business to Sikich in a transaction valued at $100 million.ManpowerGroup will recognize a gain on sale in Q2, the company said, adding that the transaction closed on Thursday.The company will receive net cash proceeds at closing of approximately $88 million after working capital and other items, and it plans to use the proceeds to strengthen its balance sheet, according to a statement.Price: $30.40, Change: $-0.28, Percent Change: -0.91%
Sector Update: Financial Stocks Advance Thursday Afternoon
Financial stocks were higher Thursday afternoon, with the NYSE Financial Index rising 0.8% and the State Street Financial Select Sector SPDR ETF (XLF) up 0.3%.The Philadelphia Housing Index was up 1.1%, and the State Street Real Estate Select Sector SPDR ETF (XLRE) added 1%.Bitcoin (BTC-USD) rose 0.6% to $76,227, and the yield for 10-year US Treasuries was decreasing 2.4 basis points to 4.39%.In economic news, the core personal consumption expenditures price index, the Federal Reserve's preferred inflation gauge, rose to 3.2% year-on-year in March from 3%, meeting expectations. It climbed 0.3% month-over-month, down from the 0.4% reported in February.US economic growth, measured by gross domestic product, rose by 2.0% in Q1 after a 0.5% gain in Q4, slower than a 2.3% increase expected in a survey compiled by Bloomberg.US initial jobless claims fell to 189,000 in the week ended April 25 from an upwardly revised 215,000 in the previous week, against expectations for a rise to 212,000 in a Bloomberg survey.In sector news, the US Senate unanimously passed Thursday a rule prohibiting its members from trading on prediction markets, effective immediately, CNBC reported.In corporate news, KKR (KKR) is considering selling the Flora Food Group spreads business, seeking to strike a deal at a valuation of up to $10 billion, the Financial Times reported. KKR shares climbed 4.2%.Mastercard's (MA) Q1 results outpaced Wall Street's estimates, but the company said that the Middle East conflict was impacting spending on cross-border travel. Its shares fell 4.7%.Brookfield Asset Management (BAM) is preparing to file draft documents as early as May for an initial public offering of Indian telecommunications tower operator Altius Telecom Infrastructure Trust, Bloomberg reported. Brookfield shares rose 3.9%.
Research Alert: CFRA Maintains Buy Rating On Shares Of The Cigna Group
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month price target to $330 from $320, based on a 10.9x multiple of our 2026 EPS estimate, near CI's five-year historical forward average of 11.2x. We think CI's multiple balances pharmaceutical business momentum in CI's Evernorth segment and a timely portfolio shift toward more commercial exposure, offset by near-term challenges around higher medical costs across the managed care space. We raise our 2026 EPS estimate by $0.01 to $30.35 and lower 2027's by $0.09 to $33.42. Following Q1 results that beat consensus views, CI's annual Medical Care Ratio (MCR) guidance was maintained at 83.7% to 84.7% for 2026, suggesting cost discipline within a challenging operating environment for managed care. The company plans to exit the Individual ACA Exchange market by year-end 2026, citing the relatively small exposure relative to other parts of CI's portfolio and challenges with meaningfully scaling operations.